AstraZeneca - Comment
Posted : 09/30/2008     ID ：FDA-2008-D-0413-0003     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

SOCMA's Bulk Pharmaceuticals Task Force - Comment
Posted : 10/01/2008     ID ：FDA-2008-D-0413-0004     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

sanofi-aventis - Comment
Posted : 10/03/2008     ID ：FDA-2008-D-0413-0005     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

Covidien - Comment
Posted : 10/04/2008     ID ：FDA-2008-D-0413-0006     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

Pfizer, Inc. - Comment
Posted : 10/07/2008     ID ：FDA-2008-D-0413-0007     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

IPEC - Comment
Posted : 10/07/2008     ID ：FDA-2008-D-0413-0008     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

International Pharmaceutical Excipients Council of the Americas - Comment
Posted : 10/07/2008     ID ：FDA-2008-D-0413-0009     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

BASF Corporation (BC) - Comment
Posted : 10/08/2008     ID ：FDA-2008-D-0413-0010     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

Schering Plough Corporation - Comment
Posted : 10/08/2008     ID ：FDA-2008-D-0413-0011     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

Yannick Lefevre (PCAS) - Comment
Posted : 10/10/2008     ID ：FDA-2008-D-0413-0012     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 10/16/2008     ID ：FDA-2008-D-0413-0013     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET

Teva Parenteral Medicines - Comment
Posted : 10/30/2008     ID ：FDA-2008-D-0413-0014     Agency : FDA

Comment Period Closed
Jan 01,0001 12:00 AM ET